Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

ACIU

AC Immune (ACIU)

AC Immune SA
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:ACIU
일자시간출처헤드라인심볼기업
2024/05/1703:23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACIUAC Immune SA
2024/05/1319:16Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ACIUAC Immune SA
2024/05/1319:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ACIUAC Immune SA
2024/02/1006:30Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ACIUAC Immune SA
2024/01/2221:53Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ACIUAC Immune SA
2024/01/0406:19Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ACIUAC Immune SA
2024/01/0322:10GlobeNewswire Inc.AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer's and Parkinson diseasesNASDAQ:ACIUAC Immune SA
2023/12/2906:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACIUAC Immune SA
2023/12/1922:53Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ACIUAC Immune SA
2023/12/1607:27Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ACIUAC Immune SA
2023/12/1606:31Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACIUAC Immune SA
2023/12/1521:27Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ACIUAC Immune SA
2023/12/1206:18Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACIUAC Immune SA
2023/12/0706:37Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACIUAC Immune SA
2023/12/0121:13Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ACIUAC Immune SA
2023/11/0320:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ACIUAC Immune SA
2023/08/2305:17Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACIUAC Immune SA
2023/08/2205:23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACIUAC Immune SA
2023/08/1805:15Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACIUAC Immune SA
2023/08/1005:16Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACIUAC Immune SA
2023/08/0905:20Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACIUAC Immune SA
2023/08/0420:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ACIUAC Immune SA
2023/07/2620:17Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:ACIUAC Immune SA
2023/07/2505:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACIUAC Immune SA
2023/07/2205:08Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACIUAC Immune SA
2023/07/1905:09Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACIUAC Immune SA
2023/07/1405:23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACIUAC Immune SA
2023/07/1305:07Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACIUAC Immune SA
2023/07/1105:15Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACIUAC Immune SA
2023/07/0805:14Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ACIUAC Immune SA
 검색 관련기사 보기:NASDAQ:ACIU